SCHEMBL23917960

SCHEMBL23917960

ClP1OCC2CCCN21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2411906 1.00
SCHEMBL2408898 1.00
SCHEMBL19375719 0.76
SCHEMBL19375422 0.76
SCHEMBL12279504 0.71
SCHEMBL20806118 0.71
SCHEMBL21147833 0.71
SCHEMBL12279592 0.71
SCHEMBL19375423 0.70
SCHEMBL22260415 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024024935-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT 第一三共株式会社 2024-02-01 WO disclosed
US-20210317158-A1 OPTICALLY ACTIVE SEGMENT FOR USE IN SYNTHESIS OF STEREOCONTROLLED OLIGONUCLEOTIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR SYNTHESIZING STEREOCONTROLLED OLIGONUCLEOTIDE USING THE SAME Natias Inc. (JP) 2021-10-14 US disclosed